Sort
23,748 grants matching “melanoma”
Polarized DC as Melanoma Vaccine: Phase 1 Evaluation
$286,396Pawel Kalinski · University Of Pittsburgh At Pittsburgh · R21 · FY2006 · CA
Academic Training in Medical Oncology
$286,323University Of California Los Angeles · T32 · FY2005 · CA
EMMPRIN: from biology to molecular mechanism
$286,298Elan Z Eisenmesser · University Of Colorado Denver · R01 · FY2014 · GM
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC
$286,283James P Allison · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Promoting the generation of long-lived, anti-tumor memory T cells with IFN-alpha
$286,213Willem W Overwijk · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Promoting the generation of long-lived, anti-tumor memory T cells with IFN-alpha
$286,213Willem W Overwijk · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Cellular Therapy
$286,212James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
EMMPRIN: from biology to molecular mechanism
$286,166Elan Z Eisenmesser · University Of Colorado Denver · R01 · FY2015 · GM
Anti-CD20 CTL for Therapy of Mantle Cell Lymphoma
$286,141Oliver W. Press · Fred Hutchinson Cancer Research Center · R21 · FY2007 · CA
A Novel Vaccine Platform for Preventing Zika Virus Infection
$286,125Richard B. Markham · Johns Hopkins University · R21 · FY2017 · AI
Cancer Immunotherapy Targeting Endothelial Antigens
$286,084Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2007 · CA
Transduction of Hematopoietic Stem Cells for Enhanced Immunotherapy of Melanoma
$286,084Donald B Kohn · California Institute Of Technology · P01 · FY2011 · CA
Core 1: Biospecimen and Translational Pathology Core
$286,076Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Interactions of ES Cells with 3D Biomaterials
$286,045Krishnendu Roy · University Of Texas At Austin · R01 · FY2008 · EB
Myxoma Virus (MV) Oncolysis for treating human cancer
$286,022Grant McFadden · University Of Florida · R01 · FY2014 · CA
The role of HEF1 protein in division and invasion of metastatic breast cancer
$286,022Elena Nikolaevna Pugacheva · West Virginia University · R01 · FY2014 · CA
The integrated stress response and the microenvironment in melanoma progression
$285,994Constantinos Koumenis · University Of Pennsylvania · R01 · FY2025 · CA
Ligand Recognition by Phospholipid Growth Factor Receptors
$285,892Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2007 · CA
Ligand Recognition by Phospholipid Growth Factor Receptors
$285,763Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2008 · CA
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer
$285,749Mohammad Athar · University Of Alabama At Birmingham · R01 · FY2013 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$285,722Indiana Univ-Purdue Univ At Indianapolis · U10 · FY2000 · CA
PRECLINICAL STUDY OF PEPTIDE BASED HUMAN TUMOR VACCINES
$285,712University Of Virginia Charlottesville · R01 · FY2000 · CA
Regulation of CXCR4 Signaling
$285,665Jeffrey L Benovic · Thomas Jefferson University · R01 · FY2011 · CA
TCR TRANSDUCED CDB T CELLS FOR ADOPTIVE IMMUNOTHERAPY
$285,652Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Engineered T Cell Therapy for Melanoma
$285,642Robert H Vonderheide · Wistar Institute · P50 · FY2018 · CA